Neuehealth Stock Performance
| NEUE Stock | 4.84 0.30 5.84% |
On a scale of 0 to 100, NeueHealth holds a performance score of 5. The company secures a Beta (Market Risk) of 0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NeueHealth's returns are expected to increase less than the market. However, during the bear market, the loss of holding NeueHealth is expected to be smaller as well. Please check NeueHealth's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether NeueHealth's current price movements will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NeueHealth are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, NeueHealth exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (5.84) | Five Day Return (26.67) | Year To Date Return (33.97) | Ten Year Return (99.64) | All Time Return (99.64) |
Last Split Factor 1:80 | Last Split Date 2023-05-22 |
1 | Acquisition by New Enterprise Associates 15, L.p. of 61865 shares of NeueHealth at 0.01 subject to Rule 16b-3 | 01/08/2025 |
2 | SHAREHOLDER NOTICE Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders | 01/10/2025 |
3 | IN SAUDI-ARABIEN, GLEICH ZUM ERSTEN MAL FR DAS NEUE FITNESS-EVENT | 02/11/2025 |
4 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of ... | 02/13/2025 |
5 | Disposition of 317 shares by Jay Matushak of NeueHealth at 6.05 subject to Rule 16b-3 | 02/21/2025 |
6 | NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025 | 02/26/2025 |
7 | Disposition of 58877 shares by Mikan George Lawrence Iii of NeueHealth subject to Rule 16b-3 | 03/06/2025 |
8 | Disposition of 7565 shares by Mikan George Lawrence Iii of NeueHealth subject to Rule 16b-3 | 03/07/2025 |
9 | Disposition of 1604 shares by Mikan George Lawrence Iii of NeueHealth at 7.06 subject to Rule 16b-3 | 03/10/2025 |
10 | Disposition of 3747 shares by Mikan George Lawrence Iii of NeueHealth at 6.85 subject to Rule 16b-3 | 03/11/2025 |
11 | Disposition of 35896 shares by Mikan George Lawrence Iii of NeueHealth at 6.74 subject to Rule 16b-3 | 03/13/2025 |
12 | NeueHealth, Inc. Short Interest Update | 03/18/2025 |
| Begin Period Cash Flow | 1.9 B | |
| Free Cash Flow | -2.7 B |
NeueHealth |
NeueHealth Relative Risk vs. Return Landscape
If you would invest 395.00 in NeueHealth on December 19, 2024 and sell it today you would earn a total of 89.00 from holding NeueHealth or generate 22.53% return on investment over 90 days. NeueHealth is currently generating 0.746% in daily expected returns and assumes 10.5584% risk (volatility on return distribution) over the 90 days horizon. In different words, 94% of stocks are less volatile than NeueHealth, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NeueHealth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeueHealth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NeueHealth, and traders can use it to determine the average amount a NeueHealth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0707
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NEUE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.56 actual daily | 94 94% of assets are less volatile |
Expected Return
| 0.75 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average NeueHealth is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeueHealth by adding it to a well-diversified portfolio.
NeueHealth Fundamentals Growth
NeueHealth Stock prices reflect investors' perceptions of the future prospects and financial health of NeueHealth, and NeueHealth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NeueHealth Stock performance.
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.051 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 960.6 M | ||||
| Shares Outstanding | 8.29 M | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 1.16 B | ||||
| Gross Profit | 174.78 M | ||||
| EBITDA | (566.8 M) | ||||
| Net Income | (1.15 B) | ||||
| Total Debt | 370.35 M | ||||
| Book Value Per Share | (163.68) X | ||||
| Cash Flow From Operations | (2.73 B) | ||||
| Earnings Per Share | 4.07 X | ||||
| Market Capitalization | 42.59 M | ||||
| Total Asset | 1.23 B | ||||
| Retained Earnings | (4.31 B) | ||||
| Working Capital | (302.33 M) | ||||
About NeueHealth Performance
By analyzing NeueHealth's fundamental ratios, stakeholders can gain valuable insights into NeueHealth's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NeueHealth has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NeueHealth has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.6 K | 818 | |
| Return On Tangible Assets | (1.17) | (1.11) | |
| Return On Capital Employed | 3.13 | 3.29 | |
| Return On Assets | (1.08) | (1.03) | |
| Return On Equity | 3.02 | 3.17 |
Things to note about NeueHealth performance evaluation
Checking the ongoing alerts about NeueHealth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NeueHealth help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NeueHealth is way too risky over 90 days horizon | |
| NeueHealth appears to be risky and price may revert if volatility continues | |
| NeueHealth has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.16 B. Net Loss for the year was (1.15 B) with profit before overhead, payroll, taxes, and interest of 174.78 M. | |
| NeueHealth generates negative cash flow from operations | |
| About 64.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: NeueHealth, Inc. Short Interest Update |
- Analyzing NeueHealth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NeueHealth's stock is overvalued or undervalued compared to its peers.
- Examining NeueHealth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NeueHealth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NeueHealth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NeueHealth's stock. These opinions can provide insight into NeueHealth's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |